RCMC
JAZZ icon

RK Capital Management (Colorado)’s Jazz Pharmaceuticals JAZZ Stock Holding History

RK Capital Management (Colorado)’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-110,820
Closed -$13.3M – 44
2024
Q1 		$13.3M Buy
110,820
+18,800
+20% +$2.3M 2.7% 18
2023
Q4 		$11.3M Sell
92,020
-48,875
-35% -$6.1M 2.41% 18
2023
Q3 		$18.2M Sell
140,895
-465
-0.3% -$62K 4.32% 1
2023
Q2 		$17.5M Buy
141,360
+6,490
+5% +$873K 3.76% 3
2023
Q1 		$19.7M Buy
134,870
+5,685
+4% +$841K 4.34% 1
2022
Q4 		$20.6M Buy
129,185
+14,940
+13% +$2.19M 4.88% 1
2022
Q3 		$15.2M Buy
114,245
+5,990
+6% +$911K 3.9% 5
2022
Q2 		$16.9M Buy
108,255
+8,050
+8% +$1.24M 3.97% 2
2022
Q1 		$15.6M Sell
100,205
-12,575
-11% -$1.82M 3.06% 6
2021
Q4 		$14.4M Buy
112,780
+41,905
+59% +$5.51M 2.61% 11
2021
Q3 		$9.23M Buy
70,875
+3,340
+5% +$505K 1.75% 24
2021
Q2 		$12M Sell
67,535
-865
-1% -$150K 2.25% 8
2021
Q1 		$11.2M Sell
68,400
-11,100
-14% -$1.83M 2.24% 6
2020
Q4 		$13.1M Buy
79,500
+1,800
+2% +$268K 2.9% 3
2020
Q3 		$11.1M Sell
77,700
-12,200
-14% -$1.51M 3.14% 3
2020
Q2 		$9.92M Buy
89,900
+21,500
+31% +$2.38M 2.9% 5
2020
Q1 		$6.82M Sell
68,400
-4,700
-6% -$608K 3.07% 9
2019
Q4 		$10.9M Sell
73,100
-20,990
-22% -$2.86M 4.09% 3
2019
Q3 		$12.1M Buy
94,090
+18,090
+24% +$2.42M 4.41% 2
2019
Q2 		$10.8M Buy
76,000
+7,600
+11% +$1.02M 3.35% 9
2019
Q1 		$9.78M Buy
68,400
+29,300
+75% +$3.82M 2.82% 10
2018
Q4 		$4.85M Sell
39,100
-40,800
-51% -$6.05M 1.38% 26
2018
Q3 		$13.4M Buy
79,900
+9,300
+13% +$1.6M 3.04% 9
2018
Q2 		$12.2M Sell
70,600
-34,300
-33% -$5.61M 2.68% 13
2018
Q1 		$15.8M Buy
104,900
+58,900
+128% +$8.64M 3.44% 5
2017
Q4 		$6.19M Buy
46,000
+1,276
+3% +$177K 1.3% 40
2017
Q3 		$6.54M Sell
44,724
-52,500
-54% -$7.94M 1.52% 36
2017
Q2 		$15.1M Sell
97,224
-25,200
-21% -$3.85M 3.04% 5
2017
Q1 		$17.8M Sell
122,424
-6,600
-5% -$860K 3.44% 4
2016
Q4 		$14.1M Sell
129,024
-12,376
-9% -$1.38M 2.91% 9
2016
Q3 		$17.2M Sell
141,400
-18,100
-11% -$2.44M 3.34% 8
2016
Q2 		$22.5M Buy
159,500
+8,600
+6% +$1.27M 4.02% 4
2016
Q1 		$19.7M Buy
150,900
+3,100
+2% +$386K 3.26% 10
2015
Q4 		$20.8M Buy
147,800
+79,200
+115% +$11M 3.63% 6
2015
Q3 		$9.11M Hold
68,600
– – 1.67% 29
2015
Q2 		$12.1M Buy
68,600
+12,600
+23% +$2.26M 2.19% 19
2015
Q1 		$9.68M Sell
56,000
-27,703
-33% -$4.75M 1.93% 25
2014
Q4 		$13.7M Buy
83,703
+19,200
+30% +$3.19M 2.71% 10
2014
Q3 		$10.4M Sell
64,503
-26,200
-29% -$4.03M 2.12% 25
2014
Q2 		$13.3M Sell
90,703
-500
-0.5% -$69.3K 2.66% 10
2014
Q1 		$12.6M Buy
91,203
+13,100
+17% +$1.97M 2.56% 10
2013
Q4 		$9.88M Sell
78,103
-20,600
-21% -$2.13M 2.43% 13
2013
Q3 		$9.08M Buy
+98,703
New +$7.96M 2.59% 9

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return

RK Capital Management (Colorado)'s JAZZ Position: Q2 2024 in Review

RK Capital Management (Colorado) sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2024, closing a stake of 110,820 shares — an estimated $13.3M sold.

RK Capital Management (Colorado) first reported a position in JAZZ in Q3 2013 and held it in 43 quarters. The position peaked at $22.5M in Q2 2016. 455 funds tracked by Wall St. Rank hold JAZZ as of Q2 2024.

  • RK Capital Management (Colorado) reported no remaining Jazz Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • RK Capital Management (Colorado) sold 110,820 Jazz Pharmaceuticals shares in Q2 2024, an estimated $13.3M.
  • RK Capital Management (Colorado) first reported a position in Jazz Pharmaceuticals in Q3 2013 and held it in 43 quarters.
  • RK Capital Management (Colorado)'s Jazz Pharmaceuticals position peaked at $22.5M in Q2 2016.
  • 455 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2024.

Based on RK Capital Management (Colorado)'s 13F filing for Q2 2024, filed 13 Aug 2024.